Cargando…

Toxoplasma gondii exposure and Parkinson's disease: a case–control study

OBJECTIVES: To determine the association between Toxoplasma gondii infection and Parkinson's disease and to investigate whether T. gondii seropositivity is associated with the general characteristics of patients with Parkinson's disease. DESIGN: Case–control study. SETTING: Cases and contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarado-Esquivel, Cosme, Méndez-Hernández, Edna Madai, Salas-Pacheco, José Manuel, Ruano-Calderón, Luis Ángel, Hernández-Tinoco, Jesús, Arias-Carrión, Oscar, Sánchez-Anguiano, Luis Francisco, Castellanos-Juárez, Francisco Xavier, Sandoval-Carrillo, Ada Agustina, Liesenfeld, Oliver, Ramos-Nevárez, Agar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318570/
https://www.ncbi.nlm.nih.gov/pubmed/28193849
http://dx.doi.org/10.1136/bmjopen-2016-013019
_version_ 1782509217813364736
author Alvarado-Esquivel, Cosme
Méndez-Hernández, Edna Madai
Salas-Pacheco, José Manuel
Ruano-Calderón, Luis Ángel
Hernández-Tinoco, Jesús
Arias-Carrión, Oscar
Sánchez-Anguiano, Luis Francisco
Castellanos-Juárez, Francisco Xavier
Sandoval-Carrillo, Ada Agustina
Liesenfeld, Oliver
Ramos-Nevárez, Agar
author_facet Alvarado-Esquivel, Cosme
Méndez-Hernández, Edna Madai
Salas-Pacheco, José Manuel
Ruano-Calderón, Luis Ángel
Hernández-Tinoco, Jesús
Arias-Carrión, Oscar
Sánchez-Anguiano, Luis Francisco
Castellanos-Juárez, Francisco Xavier
Sandoval-Carrillo, Ada Agustina
Liesenfeld, Oliver
Ramos-Nevárez, Agar
author_sort Alvarado-Esquivel, Cosme
collection PubMed
description OBJECTIVES: To determine the association between Toxoplasma gondii infection and Parkinson's disease and to investigate whether T. gondii seropositivity is associated with the general characteristics of patients with Parkinson's disease. DESIGN: Case–control study. SETTING: Cases and controls were enrolled in Durango City, Mexico. PARTICIPANTS: 65 patients with Parkinson's disease and 195 age- and gender-matched control subjects without Parkinson's disease. PRIMARY AND SECONDARY OUTCOME MEASURES: Serum samples of participants were analysed for anti-T. gondii IgG and IgM antibodies by commercially available enzyme-linked immunoassays. Prevalence of T. gondii DNA was determined in seropositive subjects using PCR. The association between clinical data and infection was examined by bivariate analysis. RESULTS: Anti-T. gondii IgG antibodies were found in 6/65 cases (9.2%) and in 21/195 controls (10.8%) (OR 0.84; 95% CI 0.32 to 2.18; p=0.81). The frequency of high (>150 IU/mL) antibody levels was similar among cases and controls (p=0.34). None of the anti-T. gondii IgG positive cases and four of the anti-T. gondii IgG positive controls had anti-T. gondii IgM antibodies (p=0.54). The prevalence of T. gondii DNA was comparable in seropositive cases and controls (16.7% and 25%, respectively; p=1.0). Seroprevalence of T. gondii infection was associated with a young age onset of disease (p=0.03), high Unified Parkinson Disease Rating Scale scores (p=0.04) and depression (p=0.02). Seropositivity to T. gondii infection was lower in patients treated with pramipexole than in patients without this treatment (p=0.01). However, none of the associations remained significant after Bonferroni correction. CONCLUSIONS: The results do not support an association between T. gondii infection and Parkinson's disease. However, T. gondii infection might have an influence on certain symptoms of Parkinson's disease. Further research to elucidate the role of T. gondii exposure on Parkinson's disease is warranted.
format Online
Article
Text
id pubmed-5318570
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53185702017-02-27 Toxoplasma gondii exposure and Parkinson's disease: a case–control study Alvarado-Esquivel, Cosme Méndez-Hernández, Edna Madai Salas-Pacheco, José Manuel Ruano-Calderón, Luis Ángel Hernández-Tinoco, Jesús Arias-Carrión, Oscar Sánchez-Anguiano, Luis Francisco Castellanos-Juárez, Francisco Xavier Sandoval-Carrillo, Ada Agustina Liesenfeld, Oliver Ramos-Nevárez, Agar BMJ Open Infectious Diseases OBJECTIVES: To determine the association between Toxoplasma gondii infection and Parkinson's disease and to investigate whether T. gondii seropositivity is associated with the general characteristics of patients with Parkinson's disease. DESIGN: Case–control study. SETTING: Cases and controls were enrolled in Durango City, Mexico. PARTICIPANTS: 65 patients with Parkinson's disease and 195 age- and gender-matched control subjects without Parkinson's disease. PRIMARY AND SECONDARY OUTCOME MEASURES: Serum samples of participants were analysed for anti-T. gondii IgG and IgM antibodies by commercially available enzyme-linked immunoassays. Prevalence of T. gondii DNA was determined in seropositive subjects using PCR. The association between clinical data and infection was examined by bivariate analysis. RESULTS: Anti-T. gondii IgG antibodies were found in 6/65 cases (9.2%) and in 21/195 controls (10.8%) (OR 0.84; 95% CI 0.32 to 2.18; p=0.81). The frequency of high (>150 IU/mL) antibody levels was similar among cases and controls (p=0.34). None of the anti-T. gondii IgG positive cases and four of the anti-T. gondii IgG positive controls had anti-T. gondii IgM antibodies (p=0.54). The prevalence of T. gondii DNA was comparable in seropositive cases and controls (16.7% and 25%, respectively; p=1.0). Seroprevalence of T. gondii infection was associated with a young age onset of disease (p=0.03), high Unified Parkinson Disease Rating Scale scores (p=0.04) and depression (p=0.02). Seropositivity to T. gondii infection was lower in patients treated with pramipexole than in patients without this treatment (p=0.01). However, none of the associations remained significant after Bonferroni correction. CONCLUSIONS: The results do not support an association between T. gondii infection and Parkinson's disease. However, T. gondii infection might have an influence on certain symptoms of Parkinson's disease. Further research to elucidate the role of T. gondii exposure on Parkinson's disease is warranted. BMJ Publishing Group 2017-02-13 /pmc/articles/PMC5318570/ /pubmed/28193849 http://dx.doi.org/10.1136/bmjopen-2016-013019 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Infectious Diseases
Alvarado-Esquivel, Cosme
Méndez-Hernández, Edna Madai
Salas-Pacheco, José Manuel
Ruano-Calderón, Luis Ángel
Hernández-Tinoco, Jesús
Arias-Carrión, Oscar
Sánchez-Anguiano, Luis Francisco
Castellanos-Juárez, Francisco Xavier
Sandoval-Carrillo, Ada Agustina
Liesenfeld, Oliver
Ramos-Nevárez, Agar
Toxoplasma gondii exposure and Parkinson's disease: a case–control study
title Toxoplasma gondii exposure and Parkinson's disease: a case–control study
title_full Toxoplasma gondii exposure and Parkinson's disease: a case–control study
title_fullStr Toxoplasma gondii exposure and Parkinson's disease: a case–control study
title_full_unstemmed Toxoplasma gondii exposure and Parkinson's disease: a case–control study
title_short Toxoplasma gondii exposure and Parkinson's disease: a case–control study
title_sort toxoplasma gondii exposure and parkinson's disease: a case–control study
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318570/
https://www.ncbi.nlm.nih.gov/pubmed/28193849
http://dx.doi.org/10.1136/bmjopen-2016-013019
work_keys_str_mv AT alvaradoesquivelcosme toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy
AT mendezhernandezednamadai toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy
AT salaspachecojosemanuel toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy
AT ruanocalderonluisangel toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy
AT hernandeztinocojesus toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy
AT ariascarrionoscar toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy
AT sanchezanguianoluisfrancisco toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy
AT castellanosjuarezfranciscoxavier toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy
AT sandovalcarrilloadaagustina toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy
AT liesenfeldoliver toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy
AT ramosnevarezagar toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy